<DOC>
	<DOCNO>NCT03016754</DOCNO>
	<brief_summary>This study design multi-center prospective observational study newly diagnose Heart Failure ( HF ) patient test hypothesis additional Ejection Fraction ( EF ) recovery occur 90 180 day Guideline Directed Medical Therapy ( GDMT ) achieve . Although study n't start day 90 , eligible , consent patient enter registry start wearable cardioverter defibrillator ( WCD ) use . The pre-study registry allow u collect early ( 90 day ) outcomes data patient likely eligible study day 90 , eligible , refuse study day 90 .</brief_summary>
	<brief_title>Heart Failure Optimization Study</brief_title>
	<detailed_description>This study conduct thirty sixty site , initially US Europe . It use observe rate recovery ventricular function ( EF &gt; 35 % ) 90 180 day newly diagnose HF patient prescribe WCD ≤ 10 day post-discharge hospitalization primary reason new onset HF ( ≤30 day since first HF hospitalization ) , ischemic non-ischemic cardiomyopathy , already use WCD 90 ± 14 day . For first 90 day WCD use , patient enrol pre-study registry . The FDA-approved WCD prescribe 6 month use hospital discharge , option longer use physician discretion . Approximately 870 subject enroll pre-study registry 750 subject study .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Arrest</mesh_term>
	<mesh_term>Death</mesh_term>
	<mesh_term>Death , Sudden , Cardiac</mesh_term>
	<criteria>Part 1 Patients ( ≥18 year old ) prescribe WCD ≤ 10 day postdischarge hospitalization primary reason new onset HF ( ≤30 day since first HF hospitalization ) , ischemic nonischemic cardiomyopathy , use WCD 30 day . Patients EF ≤ 35 % index hospitalization ( must last measurement perform multiple time ) . Part 2 Patients ( ≥18 year old ) prescribe WCD ≤ 10 day postdischarge hospitalization primary reason new onset HF ( ≤30 day since first HF hospitalization ) , ischemic nonischemic cardiomyopathy , already use WCD 90 ± 14 day . Patients EF ≤ 35 % index hospitalization ( must last measurement perform multiple time ) . Of note , EF 90 ± 14 day posthospitalization need low include study . Patients 18 year old . Patients active unipolar pacemaker . Patients physical mental condition could impair ability properly interact device . Patients currently participate another clinical study . Patients skin condition would prevent wear device . Patients advance directive prohibiting resuscitation . Patients indicate cardiac resynchronization therapy QRS duration ≥135 m . Patients recent myocardial infarction coronary revascularization ( since start WCD wear ; i.e . 090 day WCD wear ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>sudden cardiac death</keyword>
	<keyword>SCD</keyword>
	<keyword>sudden cardiac arrest</keyword>
	<keyword>SCA</keyword>
	<keyword>heart failure</keyword>
	<keyword>HF</keyword>
</DOC>